Literature DB >> 28552656

Prevalence, natural history, and time-dependent outcomes of a multi-center North American cohort of out-of-hospital cardiac arrest extracorporeal CPR candidates.

Joshua C Reynolds1, Brian E Grunau2, Jonathan Elmer3, Jon C Rittenberger3, Kelly N Sawyer3, Michael C Kurz4, Ben Singer5, Alastair Proudfoot6, Clifton W Callaway3.   

Abstract

AIM: Estimate prevalence of ECPR-eligible subjects in a large, North American, multi-center cohort, describe natural history with conventional resuscitation, and predict optimal timing of transition to ECPR.
METHODS: Secondary analysis of clinical trial enrolling adults with non-traumatic OHCA. Primary outcome was survival to discharge with favorable outcome (mRS 0-3). Subjects were additionally classified as survival with unfavorable outcome (mRS 4-5), ROSC without survival (mRS 6), or without ROSC. We plotted subject accrual as a function of resuscitation duration (CPR onset to return of spontaneous circulation (ROSC) or termination of resuscitation), and estimated time-dependent probabilities of ROSC and mRS 0-3 at discharge. Adjusted logistic regression models tested the association between resuscitation duration and survival with mRS 0-3.
RESULTS: Of 11,368 subjects, 1237 (10.9%; 95%CI 10.3-11.5%) were eligible for ECPR, Of these, 778 (63%) achieved ROSC, 466 (38%) survived to discharge, and 377 (30%) had mRS 0-3 at discharge. Half with eventual mRS 0-3 achieved ROSC within 8.8min (95%CI 8.3-9.2min) of resuscitation, and 90% within 21.0min (95%CI 19.1-23.7min). Time-dependent probabilities of ROSC and mRS 0-3 declined over elapsed resuscitation, and the likelihood of additional cases with mRS 0-3 beyond 20min was 8.4% (95%CI 5.9-11.0%). Resuscitation duration was independently associated with survival to discharge with mRS 0-3 (OR 0.95; 95%CI 0.92-0.97).
CONCLUSION: Approximately 11% of subjects were eligible for ECPR. Only one-third survived to discharge with favorable outcome. Performing 9-21min of conventional resuscitation captured most ECPR-eligible subjects with eventual mRS 0-3 at hospital discharge.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac arrest; Cardiopulmonary resuscitation; Extracorporeal CPR; Extracorporeal life support

Mesh:

Year:  2017        PMID: 28552656     DOI: 10.1016/j.resuscitation.2017.05.024

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  14 in total

1.  Sterility Duration of Preprimed Extracorporeal Membrane Oxygenation Circuits.

Authors:  Vi Ean Tan; Alan T Evangelista; Dominick M Carella; Daniel Marino; Wayne S Moore; Nadji Gilliam; Arun Chopra; Jeffrey J Cies
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Jul-Aug

2.  Association of Intra-arrest Transport vs Continued On-Scene Resuscitation With Survival to Hospital Discharge Among Patients With Out-of-Hospital Cardiac Arrest.

Authors:  Brian Grunau; Noah Kime; Brian Leroux; Thomas Rea; Gerald Van Belle; James J Menegazzi; Peter J Kudenchuk; Christian Vaillancourt; Laurie J Morrison; Jonathan Elmer; Dana M Zive; Nancy M Le; Michael Austin; Neal J Richmond; Heather Herren; Jim Christenson
Journal:  JAMA       Date:  2020-09-15       Impact factor: 56.272

3.  Traumatic and hemorrhagic complications after extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest.

Authors:  My-Linh Nguyen; Emma Gause; Brianna Mills; Joseph E Tonna; Heidi Alvey; Richard Saczkowski; Brian Grunau; Lance B Becker; David F Gaieski; Scott Youngquist; Kyle Gunnerson; Peter England; Jessica Hamilton; Jenelle Badulak; Samuel P Mandell; Eileen M Bulger; Nicholas J Johnson
Journal:  Resuscitation       Date:  2020-10-12       Impact factor: 5.262

4.  Neurological outcomes and duration from cardiac arrest to the initiation of extracorporeal membrane oxygenation in patients with out-of-hospital cardiac arrest: a retrospective study.

Authors:  Takahiro Yukawa; Masahiro Kashiura; Kazuhiro Sugiyama; Takahiro Tanabe; Yuichi Hamabe
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-09-16       Impact factor: 2.953

5.  Predictors of survival and neurologic outcome for adults with extracorporeal cardiopulmonary resuscitation: A systemic review and meta-analysis.

Authors:  Junhong Wang; Qingbian Ma; Hua Zhang; Shaoyu Liu; Yaan Zheng
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

6.  A retrospective analysis of inpatient cardiac arrests over one year at a tertiary heart attack and cardiothoracic centre identifying potential candidates for an inpatient extracorporeal cardiopulmonary resuscitation service.

Authors:  Suzanne Harrogate; Benjamin Stretch; Rosie Seatter; Simon Finney; Ben Singer
Journal:  J Intensive Care Soc       Date:  2019-05-09

Review 7.  Pre-hospital extra-corporeal cardiopulmonary resuscitation.

Authors:  Ben Singer; Joshua C Reynolds; David J Lockey; Ben O'Brien
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-03-27       Impact factor: 2.953

8.  Improved Survival With Extracorporeal Cardiopulmonary Resuscitation Despite Progressive Metabolic Derangement Associated With Prolonged Resuscitation.

Authors:  Jason A Bartos; Brian Grunau; Claire Carlson; Sue Duval; Adrian Ripeckyj; Rajat Kalra; Ganesh Raveendran; Ranjit John; Marc Conterato; Ralph J Frascone; Alexander Trembley; Tom P Aufderheide; Demetris Yannopoulos
Journal:  Circulation       Date:  2020-01-03       Impact factor: 29.690

9.  Sodium Nitroprusside-Enhanced Cardiopulmonary Resuscitation Improves Blood Flow by Pulmonary Vasodilation Leading to Higher Oxygen Requirements.

Authors:  Adrian Ripeckyj; Marinos Kosmopoulos; Kadambari Shekar; Claire Carlson; Rajat Kalra; Jennifer Rees; Tom P Aufderheide; Jason A Bartos; Demetris Yannopoulos
Journal:  JACC Basic Transl Sci       Date:  2020-02-05

Review 10.  In-Depth Extracorporeal Cardiopulmonary Resuscitation in Adult Out-of-Hospital Cardiac Arrest.

Authors:  Mark Dennis; Sean Lal; Paul Forrest; Alistair Nichol; Lionel Lamhaut; Richard J Totaro; Brian Burns; Claudio Sandroni
Journal:  J Am Heart Assoc       Date:  2020-05-06       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.